These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28828599)

  • 1. Outcomes for Women with Minimal-Volume Ductal Carcinoma In Situ Completely Excised at Core Biopsy.
    Muhsen S; Barrio AV; Miller M; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2017 Dec; 24(13):3888-3895. PubMed ID: 28828599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?
    Choi DX; Eaton AA; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2013 Apr; 20(4):1302-10. PubMed ID: 23161115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
    Solin LJ; Gray R; Hughes LL; Wood WC; Lowen MA; Badve SS; Baehner FL; Ingle JN; Perez EA; Recht A; Sparano JA; Davidson NE
    J Clin Oncol; 2015 Nov; 33(33):3938-44. PubMed ID: 26371148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ on core needle biopsy only with no residual disease at surgery.
    Dubrovsky E; Nguyen P; Chun J; Schwartz S; Raymond S; Guth A; Schnabel F; Gerber NK
    Breast J; 2018 Nov; 24(6):971-975. PubMed ID: 30062749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
    Solin LJ; Gray R; Baehner FL; Butler SM; Hughes LL; Yoshizawa C; Cherbavaz DB; Shak S; Page DL; Sledge GW; Davidson NE; Ingle JN; Perez EA; Wood WC; Sparano JA; Badve S
    J Natl Cancer Inst; 2013 May; 105(10):701-10. PubMed ID: 23641039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.
    Subhedar P; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2015 Oct; 22(10):3273-81. PubMed ID: 26215193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?
    Pilewskie M; Olcese C; Patil S; Van Zee KJ
    Ann Surg Oncol; 2016 Dec; 23(13):4253-4261. PubMed ID: 27766556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
    Sanders ME; Schuyler PA; Dupont WD; Page DL
    Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.
    Mamtani A; Nakhlis F; Downs-Canner S; Zabor EC; Morrow M; King TA; Van Zee KJ
    Ann Surg Oncol; 2019 Dec; 26(13):4264-4271. PubMed ID: 31440931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.
    Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
    Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A
    Ann Surg Oncol; 2006 Jul; 13(7):990-8. PubMed ID: 16788762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels.
    Yang L; Lu D; Lai Y; Shen M; Yu Q; Lei T; Pu T; Bu H
    Ann Surg Oncol; 2021 Feb; 28(2):975-984. PubMed ID: 32794031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
    Corradini S; Pazos M; Schönecker S; Reitz D; Niyazi M; Ganswindt U; Schrodi S; Braun M; Pölcher M; Mahner S; Harbeck N; Engel J; Belka C
    Radiat Oncol; 2018 Feb; 13(1):25. PubMed ID: 29426355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Vicini FA; Shaitelman S; Wilkinson JB; Shah C; Ye H; Kestin LL; Goldstein NS; Chen PY; Martinez AA
    Breast J; 2013; 19(4):365-73. PubMed ID: 23815268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years.
    Van Zee KJ; Subhedar P; Olcese C; Patil S; Morrow M
    Ann Surg; 2015 Oct; 262(4):623-31. PubMed ID: 26366541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
    Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
    World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.